Delivery Order SPE2DB22D1106-SPE2DB24FFHW7

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.50 firm-fixed-price delivery order contract is for the provision of 4,567,250 units of dexamethasone 2 mg tablets, a medication used to treat various medical conditions. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of dexamethasone 10 mg/ml vials. The $14,440.48 Firm Fixed Price contract is a Delivery Order that has a completion date of November 25, 2024. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.88 firm fixed-price Delivery Order contract is for the supply of 4561770671 - Dexamethasone 20 mg/5 ml vial (5 ml), with an ultimate completion date of August 11, 2023. The award is a child contract under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,723.10, is a Firm-Fixed-Price Delivery Order for the purchase of 4 mg dexamethasone tablets. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,911,624 units of Dexamethasone 20 mg/5 ml vials, a critical medication. The order has a firm fixed price of $5,562.90 and a completion date of September 24, 2024. Amerisourcebergen, through its extensive pharmaceutical supply chain, will provide this medication to support various military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,182.24 firm fixed-price delivery order is for the supply of 4566189769 dexamethasone 10 mg/ml vials. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.45 fixed-price delivery order is for the supply of DEXAMETHASONE 10 MG/ML VIALML, a critical medical commodity, with a period of performance through February 27, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of dexamethasone 10 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,943.20. This is a delivery order contract with a firm-fixed price pricing type. The period of performance runs through April 26, 2024. The contract was awarded on April 25, 2022 and did not utilize any set-aside designations, indicating open...
This federal contract award, valued at $1,454.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dexamethasone 10 mg/ml vials, a specialty medication used in various medical treatments. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4565920122 - Dexamethasone 20 mg/5 ml vial (5 ml). The firm-fixed-price contract has a ceiling value of $3,940.71 and a completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFHW7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,534,775 units of dexamethasone 4 mg tablets. The award, valued at $2,972.06, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for a broad range of medical commodities to support military treatment facilities worldwide. The contract has a firm fixed-price pricing structure and an ultimate completion date of August 22, 2024. This award does not have a set-aside designation.

Generated 11/20/24, 9:08 AM